Quantitative Analysis of the Levels of Expression of Muscarinic Receptor Subtype RNA in the Detrusor Muscle of Patients with Overactive Bladder

Author： Hinata N.  

Publisher： Adis International

ISSN： 1084-8592

Source： Molecular Diagnosis, Vol.8, Iss.1, 2004-01, pp. : 17-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of the ETA and ETB Endothelin Receptor Subtype mRNA in Human Detrusor Cultured Smooth Muscle Cells

By  

Urologia Internationalis, Vol. 65, Iss. 2, 2000-10 ,pp. : 68-72

Karger

Access to resources Recommend Favorite

Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder

By Teng Lesheng   Jiang Chaojun   Sun Fengying   Li Chunmei   Teng Lirong   Meng Qingfan   Lee Robert J.   Li Youxin  

Journal of Microencapsulation, Vol. 30, Iss. 2, 2013-03 ,pp. : 116-123

Informa Healthcare

Access to resources Recommend Favorite

Darifenacin: a selective M3 muscarinic receptor antagonist for the treatment of overactive bladder

By Smith Phillip P   Lai H Henry   Appell Rodney A  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 723-732

Future Medicine

Access to resources Recommend Favorite

Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 128-134

Bentham Science Publishers

Access to resources Recommend Favorite

The efficacy and tolerability of tarafenacin, a new muscarinic acetylcholine receptor M3 antagonist in patients with overactive bladder; randomised, double‐blind, placebo‐controlled phase 2 study

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 2, 2015-02 ,pp. : 242-250

John Wiley & Sons Inc

Access to resources Recommend Favorite